Qaelon’s Triple Threat Platform Is Redefining the Future OR

September 24, 2026 -- The battle for the operating room is intensifying. Robotic systems and video platforms are rapidly converging around visualization, workflow automation, and surgical intelligence — and the next breakthroughs will come from technologies that deliver new physiologic insight and real‑time data. Qaelon Medical is bringing that shift to the OR, digitizing critical steps of surgery, stabilizing the operative environment, and generating structured physiologic data that can reshape minimally invasive care.

🔥 The Triple Threat

1️⃣ Digitized Leak Detection

Qaelon converts leak detection from a visual analog test into a real‑time digital signal. The century‑old air‑bubble test is subjective and produces no data. Qaelon delivers the first objective measure of GI integrity, detecting 1 mm defects, and generating structured physiologic data never before available in MIS.

2️⃣ Constant‑Flow Insufflation

Pulsed insufflation can’t keep up with robotic surgery. Suction, smoke evacuation, and tissue extraction cause rapid gas loss and pressure swings that disrupt visualization and stability. Constant‑flow insufflation responds instantly, maintaining the stable environment robotic surgeons require.

3️⃣ AI Ready Objective Performance Indicators (OPIs)

Qaelon creates the first structured, real-time dataset on organ integrity that surgical video alone cannot capture. Traditional leak testing produces no quantifiable signal. Qaelon’s OPIs turn physiologic signals into objective, real‑time metrics - the foundation for predictive modeling and AI‑driven decision support, built on proprietary, regulatory‑gated data no other system can generate.

The Bottom Line

The future OR will be shaped by platforms that unify visualization, automation, and real‑time physiologic insight. Qaelon’s Triple Threat is built for that future - enabling safer, more predictable surgery and ushering in the next era of minimally invasive care.

About Qaelon Medical

Qaelon Medical is pioneering the future of surgical leak detection and insufflation. Its platform integrates real-time, quantitative leak detection with intelligent constant flow insufflation for minimally invasive procedures. By replacing outdated and subjective visual tests with digital sensors and adaptive algorithms, Qaelon is designed to help surgeons identify and address potential leaks intraoperatively while generating the first objective intraoperative data on organ integrity. This new information layer has the potential to improve surgical decision-making, reduce complications and support the development of predictive insights into surgical performance and patient outcomes. Headquartered in Strasbourg, France, Qaelon is supported by industry veterans, strategic partners, and a global network of clinical innovators.

Qaelon Medical’s products are under development, have not yet received FDA clearance or CE marking, and are not currently available for commercial sale in the United States or Europe.

For more information, visit www.qaelonmedical.com or contact:

Yee Ying Douchamps yee-ying.douchamps@qaelonmedical.com